Clinical trial
MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal…
NCT00231764 · Ekberg, Henrik, M.D., Other · Completed
Key facts
| NCT number | NCT00231764 |
|---|---|
| Title | MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients |
| Official title | Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx |
| Lead sponsor | Ekberg, Henrik, M.D., Other |
| Collaborators | Prof. Philip Halloran, Edmonton, Canada (sponsor) Prof. Yves Vanrenterghem, Leuven, Belgium (Steering Committee Member) Prof. Pierre Daloze, Montréal, Canada (Steering Committee Member) Prof. Thomas… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | daclizumab |
| Enrollment | 1,760 |
| Start date | Nov 1, 2002 |
| Primary completion | May 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 24, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: